Portfolio of Coronavirus Stocks

The following table includes 21 coronavirus treatment and vaccine stocks.

21 Coronavirus Stocks
Name & Monthly Returns	Symbol & Snapshot	Recent Prices & Trendline Chart
Abbott Laboratories	ABT
Aethlon Medical	AEMD
AIM ImmunoTech	AIM
Alpha Pro Tech	APT
BioCryst Pharmaceuticals	BCRX
Cleveland BioLabs	CBLI
Co-Diagnostics	CODX
Emergent BioSolutions	EBS
Gilead Sciences	GILD
InflaRx N.V.	IFRX
Inovio Pharmaceuticals	INO
Lakeland Industries	LAKE
Mesoblast Limited	MESO
Moderna	MRNA
NanoViricides	NNVC
Novavax	NVAX
Ocean Bio-Chem	OBCI
Regeneron Pharmaceuticals	REGN
Roche Holding	RHHBY
Tonix Pharmaceuticals	TNXP
Vir Biotechnology	VIR
Price charts from Alpha Vantage as of most recent close.

Portfolio Values

To inspect the performance of the Coronavirus Stocks portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Alpha Vantage.

The 15 stocks included in the portfolio computations are: ABT, AIM, APT, BCRX, CBLI, EBS, GILD, INO, LAKE, NNVC, NVAX, OBCI, REGN, RHHBY and TNXP. The current value of the portfolio assumes that $666.67 was invested (total of $10,000) in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends. The 6 stocks excluded from the portfolio computations because of insufficient price data are: AEMD, CODX, IFRX, MESO, MRNA and VIR.

The current value of a $10,000 investment is $9,396. The percent return is -6.04%. The annualized return is -1.24%.

See Portfolio of Coronavirus Treatment and Vaccine Stocks.

See Portfolio of Coronavirus Vaccine Stocks.

See Portfolio of Coronavirus Virus Lockdown Stocks.